You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Molika Ashford covers personalized medicine and molecular diagnostics for GenomeWeb.
The company recently announced a deal with personalized ctDNA testing firm Natera and will now follow that with the launch of its own MRD product this year.
The company doesn’t expect significant revenue from the test this year, but executives said that they are already seeing positive reception trends.
The sequencing test involves a single library preparation that is then split for parallel analysis of promoter methylation, MSI calculation, and gene mutation detection.
The company plans to publish new data on clinical sensitivity and specificity and has initiated multiple studies investigating new use cases.
With its liquid biopsy test FDA approved and monitoring and screening offerings poised for launch, the firm is turning its attention to tumor tissue testing.
Later this year, the inherited cardiovascular disease clinic also plans to implement a preventive genomics program with polygenic risk score and PGx testing.
Investigators reported that the classifier could correctly predict cancer type with over 94 percent accuracy and highlighted impacts in a commercially tested cohort.
The company had been working to expand its retrospective data over the last year and half and is now readying to move forward with prospective studies.
Backed by large public companies and growing prospective data, the first molecular blood tests to screen for multiple cancers are approaching commercialization.
Early data around an initial composite assay showed it can predict immunooncology drug responses more accurately than tumor mutational burden.
Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.
Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.
Science reports that a Dutch research funding agency is combating a ransomware attack.
In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.